Shuren on FDA's future: 'Where do we go from here? ... Who knows?'
In a webinar hosted by the medtech development service provider NAMSA, the former long-time chief of CDRH, Jeff Shuren, M.D., said the loss of 3,500 full-time positions through the agency’s recent reduction-in-force would assuredly impact the pace of its work.
In a webinar hosted by the medtech development service provider NAMSA, the former long-time chief of CDRH, Jeff Shuren, M.D., said the loss of 3,500 full-time positions through the agency’s recent reduction-in-force would assuredly impact the pace of its work.
